Literature DB >> 27578064

Epidemiology of Itch.

Elke Weisshaar1.   

Abstract

Epidemiology is the study of disease frequency and the associations between risk factors and outcome in a population. Clinical populations are highly selective and depend for instance on perceived severity of symptoms and access to health services. Assessment of a disease in the community and in specific populations is an important measure for the purpose of health planning as well as for the understanding of associations between disease and factors in the environment. Itch is definitely the most frequent symptom of the skin and can occur in acute and chronic skin diseases and other diseases like end-stage renal disease, cholestasis, and hematological, neurological, and psychiatric diseases. This diversity may explain why research on the epidemiology of itch was disregarded for a long time. A recent European study demonstrated that the prevalence of itch among dermatological patients is 54.4%. The prevalence of acute itch in the general population is 8.4% and for chronic itch it is 13.5%; however, with a recurrent symptom it is important to consider different prevalence estimates (point, 12-month, and lifetime prevalence). The lifetime prevalence of chronic itch in the general populations is 22%, demonstrating that more than 1 in 5 people experience chronic itch once in their life. This shows that research in this field should not only focus on patients. This chapter briefly summarizes major facts on the epidemiology of itch in the general population and in some patient populations.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27578064     DOI: 10.1159/000446010

Source DB:  PubMed          Journal:  Curr Probl Dermatol        ISSN: 1421-5721


  8 in total

Review 1.  Neuroinflammation Involved in Diabetes-Related Pain and Itch.

Authors:  Xiao-Xia Fang; Heng Wang; Hao-Lin Song; Juan Wang; Zhi-Jun Zhang
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

2.  Neurokinin 1 Receptor Antagonists for Pruritus.

Authors:  Majid Alam; Joerg Buddenkotte; Fareed Ahmad; Martin Steinhoff
Journal:  Drugs       Date:  2021-03-06       Impact factor: 9.546

Review 3.  Acupuncture for the Treatment of Itch: Peripheral and Central Mechanisms.

Authors:  Yi Tang; Shirui Cheng; Jin Wang; Yin Jin; Haodong Yang; Qihui Lin; Sanmei Xu; Lin Hui; Quanying Yin; Ying Yang; Xi Wu
Journal:  Front Neurosci       Date:  2022-03-30       Impact factor: 4.677

4.  Development of R7BP inhibitors through cross-linking coupled mass spectrometry and integrated modeling.

Authors:  Poorni R Adikaram; Jian-Hua Zhang; Claire M Kittock; Mritunjay Pandey; Sergio A Hassan; Nicole G Lue; Guanghui Wang; Marjan Gucek; William F Simonds
Journal:  Commun Biol       Date:  2019-09-13

5.  Associations Between Interindividual Differences, Expectations and Placebo and Nocebo Effects in Itch.

Authors:  Stefanie H Meeuwis; Henriët van Middendorp; Dieuwke S Veldhuijzen; Andrea W M Evers
Journal:  Front Psychol       Date:  2021-12-13

6.  Satellite Glial Cells and Neurons in Trigeminal Ganglia Are Altered in an Itch Model in Mice.

Authors:  Meytal Cohen; Rachel Feldman-Goriachnik; Menachem Hanani
Journal:  Cells       Date:  2022-03-04       Impact factor: 6.600

Review 7.  Pruritus as a Distinctive Feature of Type 2 Inflammation.

Authors:  Simone Garcovich; Martina Maurelli; Paolo Gisondi; Ketty Peris; Gil Yosipovitch; Giampiero Girolomoni
Journal:  Vaccines (Basel)       Date:  2021-03-23

Review 8.  Saporin as a Commercial Reagent: Its Uses and Unexpected Impacts in the Biological Sciences-Tools from the Plant Kingdom.

Authors:  Leonardo R Ancheta; Patrick A Shramm; Raschel Bouajram; Denise Higgins; Douglas A Lappi
Journal:  Toxins (Basel)       Date:  2022-03-02       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.